CHILDREN'S HEALTHCARE OF ATLANTA for CHILDREN'S HEALTHCARE OF ATLANTA
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Medicaid program reforms, including telemedicine Section 340B Drug Pricing Program Sickle Cell Disease research funding generally Drug pricing reforms generally Reauthorization of Children's Hospital Graduate Medical Education program Mental and behavioral health legislation generally Children's Health Insurance Program (CHIP), regarding continuous eligibility
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMILA POPE | — |
Budget/Appropriations BUD
Autism research programs and autism intervention programs generally Department of Health and Human Services programs regarding autism and sickle cell disease research Fiscal Year 2024 Department of Health and Human Services appropriations regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, Advanced Research Projects Agency-Health, and other programs related to pediatric health care
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMILA POPE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.